Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Henryk Foks
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Phenomena
Occupations
Procedures
Disorders
Concepts & Ideas
Physiology
Sign-in to see full Profile
Network (preview)
19
Janowiec, Mieczyslaw
9
Kaliszan, Roman
9
Nasal, Antoni
7
Petrusewicz, Jacek
6
Zwolska, Zofia
6
Orlewska, Czeslawa
3
Milczarska, B
3
Lehmann, Artur
3
Andrzejczyk, Z
3
Augustynowicz-Kopec, Ewa
3
Boblewski, Konrad
3
Yacoub, Magdi
3
Rybczynska, Apolonia
3
Saczewski, Franciszek
3
Slominska, Ewa
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Henryk Foks (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Borkowski T; Orlewska C; Slominska E M; Yuen A; Lipinski M; Rybakowska I; Foks H; Kaletha K K; Yacoub M H; Smolenski R T
Pharmacological inhibition of AMP-deaminase in rat cardiac myocytes.
Nucleosides, nucleotides & nucleic acids 2008;27(6):867-71.
-
2008: Slominska E M; Orlewska C; Yuen A; Osman L; Romaszko P; Sokolowska E; Foks H; Simmonds H A; Yacoub M H; Smolenski R T
Metabolism of 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate and its nucleoside precursor in the erythrocytes.
Nucleosides, nucleotides & nucleic acids 2008;27(6):830-4.
-
2006: Rybczynska Apolonia; Lehmann Artur; Jurska-Jasko Anna; Boblewski Konrad; Orlewska Czeslawa; Foks Henryk; Drewnowska Krystyna
Hypertensive effect of calcilytic NPS 2143 administration in rats.
The Journal of endocrinology 2006;191(1):189-95.
-
2006: Slominska Ewa M; Carrey Elizabeth A; Foks Henryk; Orlewska Czeslawa; Wieczerzak Ewa; Sowinski Pawel; Yacoub Magdi H; Marinaki Anthony M; Simmonds H Anne; Smolenski Ryszard T
A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate.
The Journal of biological chemistry 2006;281(43):32057-64.
-
2006: Rybczynska Apolonia; Boblewski Konrad; Lehmann Artur; Orlewska Czeslawa; Foks Henryk
Pharmacological activity of calcimimetic NPS R-568 administered intravenously in rats: dose dependency.
Pharmacological reports : PR 2006;58(4):533-9.
-
2006: Gobis Katarzyna; Foks Henryk; Kedzia Anna; Wierzchowska Maria; Kwapisz Ewa; Zwolska Zofia; Augustynowicz-Kopec Ewa
Studies on pyrazine derivatives. XLVII. Synthesis and antibacterial activity of novel pyrazine derivatives with amidoxime moiety.
Acta poloniae pharmaceutica 2006;63(1):39-45.
-
2005: Foks Henryk; Pancechowska-Ksepko Danuta; Kedzia Anna; Zwolska Zofia; Janowiec Mieczyslaw; Augustynowicz-Kopec Ewa
Synthesis and antibacterial activity of 1H-pyrazolo[3,4-b]pyrazine and -pyridine derivatives.
Farmaco (Società chimica italiana : 1989) 2005;60(6-7):513-7.
-
2005: Rybczynska Apolonia; Boblewski Konrad; Lehmann Artur; Orlewska Czeslawa; Foks Henryk; Drewnowska Krystyna; Hoppe Anzelm
Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats.
American journal of hypertension 2005;18(3):364-71.
-
2004: Foks Henryk; Pancechowska-Ksepko Danuta; Janowiec Mieczyslaw; Zwolska Zofia; Augustynowicz-Kopec Ewa
Synthesis and tuberculostatic activity of some (4-phenylpiperazin-1-ylmethyl)-1,3,4-oxadiazole and (4-phenylpiperazin-1-ylmethyl)-1,2,4-triazole derivatives.
Acta poloniae pharmaceutica 2004;61(6):473-6.
-
2000: Milczarska B; Foks H; Mikolajczyk K; Janowiec M; Zwolska Z; Andrzejczyk Z
Studies on pyrazine derivatives--XXXIV. Synthesis and tuberculostatic activity of alpha-oxo ketene dithioacetals pyrazine derivatives.
Acta poloniae pharmaceutica 2000;57(4):307-10.
-
1999: Petrusewicz J; Siluk D; Kaliszan R; Foks H; Nowakowska E
Comparative study of antithrombotic and antiaggregatory activity of acetylsalicylic acid, ticlopidine and a new noncarboxylic acid antiinflammatory pyrazine derivative HF90.
Acta poloniae pharmaceutica 1999;56(6):463-7.
-
1999: Foks H; Wisterowicz K; Nasal A; Damasiewicz B; Radwanska A
Studies on quinoxaline derivatives. Synthesis of quinoxalylamino-1,3-diazacycloalkanes with potential hypotensive activity.
Acta poloniae pharmaceutica 1999;56(3):201-6.
-
1999: Milczarska B; Foks H; Sokolowska J; Janowiec M; Zwolska Z; Andrzejczyk Z
Studies on pyrazine derivatives. XXXIII. Synthesis and tuberculostatic activity of 1-[1-(2-pyrazinyl)-ethyl]-4-N-substituted thiosemicarbazide derivatives.
Acta poloniae pharmaceutica 1999;56(2):121-6.
-
1998: Milczarska B; Foks H; Trapkowski Z; Milzynska-Kolaczek A; Janowiec M; Zwolska Z; Andrzejczyk Z
Studies on pyrazine derivatives. XXXII. Synthesis and tuberculostatic activity of acetylpyrazine thiosemicarbazone derivatives.
Acta poloniae pharmaceutica 1998;55(4):289-95.
-
1997: Foks H; Wisterowicz K; Damasiewicz B; Nasal A; Petrusewicz J; Radwanska A
Studies on pyrazine derivatives. XXX. Synthesis of pyrazinylamino-1,3-diazacycloalkanes of potential circulatory activity.
Acta poloniae pharmaceutica 1997;54(1):55-62.
-
1995: Foks H; Czarnocka-Janowicz A; Rudnicka W; Damasiewicz B; Nasal A
Synthesis and biological activity of thiazolo-1,2,4-triazoles.
Acta poloniae pharmaceutica 1995;52(5):415-20.
-
1995: Orlewska C; Foks H; Janowiec M; Zwolskakwiek Z
Studies on pyrazine derivatives, XXIX: Synthesis of N1-thioamido substituted pyrazincarboxyamidrazones with expected tuberculostatic activity.
Die Pharmazie 1995;50(8):565-6.
-
1995: Petrusewicz J; Turowski M; Foks H; Pilarski B; Kaliszan R
Comparative studies of antiplatelet activity of nonsteroidal antiinflammatory drugs and new pyrazine CH- and NH-acids.
Life sciences 1995;56(9):667-77.
-
1993: Petrusewicz J; Gami-Yilinkou R; Kaliszan R; Pilarski B; Foks H
Pyrazine CH- and NH-acids. Antithrombotic activity and chromatographic behaviour.
General pharmacology 1993;24(1):17-22.
-
1993: Pancechowsak-Ksepko D; Foks H; Janowiec M; Zwolska-Kwiek Z
[Synthesis and tuberculostatic activity of reaction products 5-(2-,3- and 4-pyridil) -1,3,4-oxadiazol-2-thione with amines]
Acta poloniae pharmaceutica 1993;50(2-3):259-67.
-
1992: Foks H; Rudnicka W; Glowka M; Kaliszan R; Nasal A; Damasiewicz B; Radwanska A; Petrusewicz J; Trzeciak H; Okopien B
Synthesis, structure and biological activity of 1,2,4-triazolo-1,3-thiazine derivatives.
Die Pharmazie 1992;47(10):770-3.
-
1992: Foks H; Orlewska C; Janowiec M
[Study of the synthesis of pyrazine derivates. Part XXVIII. Reaction of pyrazineamide with CS-2]
Acta poloniae pharmaceutica 1992;49(5-6):47-50.
-
1992: Milczarska B; Foks H; Janowiec M; Zwolska-Kwiek Z
[Investigations of pyrazine derivatives. Part XXVII. Synthesis and tuberculostatic activity of some 6-alkoxypyrazine-2-carbotioamids]
Acta poloniae pharmaceutica 1992;49(5-6):41-5.
-
1991: Czarnocka-Janowicz A; Foks H; Nasal A; Petrusewicz J; Damasiewicz B; Radwanska A; Kaliszan R
Synthesis and pharmacological activity of 5-substituted-s-triazole-3-thiols.
Die Pharmazie 1991;46(2):109-12.
-
1989: Nasal A; Kaliszan R; Foks H; Wisterowicz K
Quantitative relationships between hydrophobicity and hypotensive activity of diazacycloalkane derivatives.
Polish journal of pharmacology and pharmacy 1989;41(6):649-57.
-
1989: Wisterowicz K; Foks H; Janowiec M; Zwolska-Kwiek Z
[Studies on pyrazine derivatives. XXVI. Synthesis and tuberculostatic activity of N-pyrazinylthiourea]
Acta poloniae pharmaceutica 1989;46(2):101-13.
-
1988: Pancechowska-Ksepko D; Foks H; Janowiec M; Zwolska-Kwiek Z
[Studies of pyrazine derivatives. XXV. Synthesis and the tuberculostatic activity of the products of reaction of 5-(6-methoxy- and 5-(6 morpholinopyrazinyl)-1,3,4-oxadiazol-2-thione with amines]
Acta poloniae pharmaceutica 1988;45(5):373-9.
-
1988: Pancechowska-Ksepko D; Foks H; Janowiec M; Zwolska-Kwiek Z
[Studies on pyrazine derivatives. XXII. Synthesis and tuberculostatic activity of the products of reactions of pyrazinyl-1,3,4-oxadiazol-2-thione with amines]
Acta poloniae pharmaceutica 1988;45(3):193-200.
-
1987: Kaliszan R; Foks H; Damasiewicz B; Nasal A; Petrusewicz J; Radwanska A; Saczewski F; Kuzmierkiewicz W
A search for new antihypertensive agents. II. Circulatory activity and selection of structures among 2-methylbenzimidazole derivatives.
Polish journal of pharmacology and pharmacy 1987;39(4):419-31.
-
1986: Kuzmierkiewicz W; Saczewski F; Foks H
Syntheses and biological activities of 2-(adamantylmethyl)benzimidazoles and -imidazolines.
Archiv der Pharmazie 1986;319(9):830-4.
-
1986: Wisterowicz K; Foks H; Strzalkowska-Grad H; Hac E; Janowiec M; Zwolska-Kwiek Z
[Synthesis and biological effect of various derivatives of 2-imidazolidinoacetonitrile]
Acta poloniae pharmaceutica 1986;43(1):25-31.
-
1986: Rudnicka W; Foks H; Janowiec M; Zwolska-Kwiek Z
[Studies of pyrazine derivatives. XXI. Synthesis and tuberculostatic activity of 4-aryl-1-pyrazinoylthiosemicarbazides and the products of their cyclization to 1,2,4-triazole-3-thione derivatives]
Acta poloniae pharmaceutica 1986;43(6):523-8.
-
1986: Pancechowska-Ksepko D; Foks H; Janowiec M; Zwolska-Kwiek Z
[Studies of pyrazine derivatives. XX. Synthesis and tuberculostatic activity of 3-pyrazinol-1,2,4-oxadiazole derivatives]
Acta poloniae pharmaceutica 1986;43(3):211-7.
-
1986: Pancechowska-Ksepko D; Foks H; Landowska E; Janowiec M; Zwolska-Kwiek Z
[Studies of pyrazine derivatives. XVII. Synthesis and the tuberculostatic activity of pyrazinyl-1,3,4-oxadiazole derivatives]
Acta poloniae pharmaceutica 1986;43(2):116-23.
-
1986: Saczewski F; Foks H; Sawlewicz J; Szulc K
[Studies of benzimidazole derivatives. XIII. Synthesis of various 2-alpha-hydroxy- and 2-beta-hydroxyalkyl-benzimidazoles]
Acta poloniae pharmaceutica 1986;43(4):299-307.
-
1985: Kuzmierkiewicz W; Foks H; Hac E; Strzalkowska-Grad H
Synthesis and analgetic and antiinflammatory activity of derivatives of 3-(1H-benzimidazole-2)propanoic acid.
Die Pharmazie 1985;40(7):462-4.
-
1985: Kaliszan R; Damasiewicz B; Nasal A; Radwanska A; Foks H; Kuzmierkiewicz W; Pancechowska-Ksepko D; Rudnicka K; Wisterowicz K; Osmialowski K
Structure and alpha-adrenergic activity of pyrazinimidazolines.
Agents and actions 1985;16(5):435-42.
-
1985: Janowiec M; Marczewska J; Stambrowska A; Foks H; Pancechowska-Ksepko D; Wrzesniowska K
[Studies on pyrazine derivatives. XVI. Antitubercular properties of compound F-369 in in vitro and in vivo studies]
Pneumonologia polska 1985;53(1):9-14.
-
1985: Kaliszan R; Foks H; Damasiewicz B; Nasal A; Radwanska A; Kuzmierkiewicz W; Pancechowska-Ksepko D; Rudnicka W; Wisterowicz K
A search for new antihypertensive agents. I. Alpha-adrenergic activity and selection of structures among pyrazine substituted imidazolines.
Polish journal of pharmacology and pharmacy 1985;37(1):79-88.
-
1983: Pancechowska-Ksepko D; Foks H; Janowiec M
[Studies on pyrazine derivatives. XIX. Synthesis and tuberculostatic activity of various 3-phenoxy-2-pyrazinecarboxylic acid derivatives]
Acta poloniae pharmaceutica 1983;40(1):15-9.
-
1982: Foks H; Janowiec M
[Studies on pyrazine derivatives. XV. Synthesis and tuberculostatic effect of imidazoline pyrazines and imidazoline pyridines]
Acta poloniae pharmaceutica 1982;39(1-3):79-82.
Sign-in to see more
